Lotus Edge becomes third TAVR system approved by FDA
Boston Scientific announced its mechanically expandable transcatheter aortic valve replacement system has been approved by the FDA for treatment of patients with severe aortic stenosis.
Metformin may reduce growth of AAA
Among veterans with diabetes and asymptomatic abdominal aortic aneurysm, those who had a prescription for metformin had slower AAA growth than those who did not, according to findings in the Journal of Vascular Surgery.
FDA grants premarket approval to supersaturated oxygen therapy for STEMI
TherOx Inc. announced that a therapy to reduce heart tissue damage in patients with left anterior descending STEMI has received premarket approval from the FDA.
Sonothrombolysis beneficial in STEMI
NEW ORLEANS — Among patients with STEMI, adding sonothrombolysis to PCI improved recanalization rates and reduced infarct size, according to findings from the MRUSMI trial presented at the American College of Cardiology Scientific Session.
Post-angioplasty dissection repair device receives FDA approval for PAD
Intact Vascular announced that a dissection repair device for patients with peripheral artery disease after undergoing an angioplasty has been approved by the FDA.
FDA grants breakthrough therapy designation for ticagrelor reversal agent
The FDA has granted breakthrough therapy designation for a novel reversal agent for the antiplatelet drug ticagrelor, according to an announcement from PhaseBio Pharmaceuticals Inc.
Survival improved over time in acute aortic dissection
NEW ORLEANS — Since 1996, survival in patients with acute aortic dissection has increased, according to data from the IRAD registry presented at the American College of Cardiology Scientific Session.
BP down with renal sympathetic denervation in sham-controlled trials
A new TAVR system, the benefits of metformin in AAA and a look at the burnout rate among interventional radiologists are among the top stories from the month of April.
Source: Adobe Stock
In a recent meta-analysis of randomized, sham-controlled trials, renal sympathetic denervation significantly decreased various measures of BP.
Survival at 30 days similar by access site in PCI for STEMI
NEW ORLEANS — Among patients who underwent PCI for STEMI, there was no difference in 30-day survival between those who had their procedure with transradial access and those who had it with transfemoral access, according to data from the SAFARI-STEMI trial.
Burnout rate more than 70% among interventional radiologists
More than 70% of interventional radiologists reported feeling burned out, according to the results of a survey presented at the Society of Interventional Radiology Annual Scientific Meeting.